Clementia Pharmaceuticals Inc.
- Raised $60 million (2015)
- 10 clinical trials
- Founded 2010
Life science companies
Explore 14,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Dermira, Inc.
- Raised $1 million (2018)
- 17 clinical trials, 1 active
- Founded 2010
Evelo Biosciences, Inc.
- Raised $82 million (2018)
- 10 clinical trials
- Founded 2014
Galmed Pharmaceuticals Ltd.
Nasdaq: EOCN
- Raised $100,000 (2017)
- 10 clinical trials, 1 active
- Founded 2013
Infinity Pharmaceuticals, Inc.
- Raised $79 million (2012)
- 24 clinical trials
Intarcia Therapeutics, Inc
- Raised $198 million (2020)
- 21 clinical trials
Nevro Corp
- Raised $59 million (2011)
- 10 clinical trials, 3 active
- Founded 2006
Alpenglow Biosciences, Inc.
- Raised $3 million (2025)
- Research grants: $6.7 million
- Founded 2018
Amplyx Pharmaceuticals, Inc.
- Raised $91 million (2020)
- Research grants: $15 million
AtlasXomics Inc.
- Raised $3.9 million (2022)
- Research grants: $6.2 million
- Founded 2020
Avails Medical, Inc.
- Raised $6.4 million (2017)
- FDA-cleared or approved devices
- Research grants: $450,000
- Founded 2013
DTx Pharma, Inc.
- Raised $100 million (2021)
- Research grants: $3.1 million
- Founded 2017
Eargo, Inc.
- Raised $82 million (2020)
- FDA-cleared or approved devices
Enterra Medical, Inc.
- Raised $19 million (2022)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2021
Hyalex Orthopaedics, Inc.
- Raised $15 million (2024)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2016
Luminopia, Inc.
- Raised $16 million (2023)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2015
MediView XR, Inc.
- Raised $14 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Founded 2019
Mitotherapeutix, LLC
- Raised $3 million (2025)
- Research grants: $6 million
- Founded 2014
Nexgel, Inc.
Nasdaq: NXGL
- Raised $1.6 million (2021)
- FDA-cleared or approved devices
R3 Vascular Inc.
- Raised $72 million (2024)
- 3 clinical trials, 3 active
- 1 FDA-registered device site
- Founded 2019
Showing 1,340 of 14,266 companies
Load morePublished company profiles only; counts update daily. Data licences